MLSS — Milestone Scientific Balance Sheet
0.000.00%
- $24.69m
- $24.20m
- $8.63m
Annual balance sheet for Milestone Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 14.2 | 14.8 | 8.72 | 5.95 | 3.26 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.08 | 0.943 | 0.694 | 0.313 | 0.475 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 18.6 | 18.9 | 13 | 10.8 | 9.29 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.663 | 0.574 | 0.479 | 0.374 | 0.338 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 19.6 | 19.8 | 13.7 | 11.4 | 9.8 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.88 | 3.1 | 3.3 | 3.08 | 3.74 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 3.37 | 3.44 | 3.48 | 3.36 | 3.96 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 16.2 | 16.4 | 10.2 | 8.01 | 5.83 |
| Total Liabilities & Shareholders' Equity | 19.6 | 19.8 | 13.7 | 11.4 | 9.8 |
| Total Common Shares Outstanding |